Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Progyny, Inc. - Common Stock (NQ:PGNY)

19.45 -0.05 (-0.23%)
Streaming Delayed Price Updated: 3:57 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Progyny, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
From Progyny, Inc.
Via GlobeNewswire
Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks
Motley Fool analysts Karl Thiel, Rick Munarriz, and Tim Beyers offer up three stocks that face dark clouds they can see through. 
Via The Motley Fool
Topics Workforce
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
Global employers can now empower their workforces with comprehensive women’s health benefits, supported by localized expertise 
From Progyny, Inc.
Via GlobeNewswire
The Analyst Verdict: Progyny In The Eyes Of 4 Experts
 
Via Benzinga
1 Safe-and-Steady Stock with Exciting Potential and 2 We Question
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
Topics Supply Chain
1 Cash-Heavy Stock to Target This Week and 2 That Underwhelm
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining... 
Via StockStory
Progyny Stock Logs Best Day In 2 Months As BofA Calls Trump IVF Policy ‘Incremental Positive’ — Traders Eye More Upside
Trump may potentially announce new measures to expand access to in-vitro fertilization, including guidance for employers to offer supplemental fertility insurance and steep discounts on key IVF drugs. 
Via Stocktwits
Topics Government World Trade
3 Stocks Under $50 with Questionable Fundamentals
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions
Washington D.C. – The Federal Reserve has sent clear signals of a continued dovish pivot, with Chair Jerome Powell indicating the likelihood of two additional quarter-point interest rate cuts before... 
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
3 Cash-Producing Stocks We Think Twice About
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
3 Reasons to Avoid PGNY and 1 Stock to Buy Instead
Over the past six months, Progyny’s shares (currently trading at $20.90) have posted a disappointing 9.1% loss, well below the S&P 500’s 18.4% gain. This might have investors contemplating their next... 
Via StockStory
Topics Stocks Supply Chain
1 Healthcare Stock with Exciting Potential and 2 We Question
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
A Healthcare Debate: Progyny vs. Hims & Hers
Motley Fool analysts take a look. 
Via The Motley Fool
Health Insurance Providers Stocks Q2 Results: Benchmarking Progyny (NASDAQ:PGNY)
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Progyny (NASDAQ:PGNY) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Anchored at 4%: Why the Steady 10-Year Treasury Yield is Key to Unlocking the Fed's Stimulus Power
The U.S. financial markets are currently at a critical juncture, with the stability of the 10-year Treasury yield hovering steadfastly around the 4% mark. This apparent calm in long-term borrowing... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
3 Profitable Stocks Walking a Fine Line
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Bond Yields Tumble as Investors Brace for Aggressive Fed Rate Cuts
U.S. Treasury yields have recently experienced a significant decline, with the benchmark 10-year Treasury note falling to its lowest levels since April 2025. This sharp dip in yields reflects a... 
Via MarketMinute
Topics Bonds Economy Supply Chain
Why Progyny (PGNY) Stock Is Trading Lower Today
Shares of fertility benefits company Progyny (NASDAQ:PGNY) fell 5.1% in the afternoon session after a broader market downturn triggered by a surprisingly weak U.S. labor market report. The decline was... 
Via StockStory
Topics Artificial Intelligence
2 Small-Cap Stocks Worth Your Attention and 1 We Brush Off
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
Progyny (PGNY) Stock Trades Up, Here Is Why
Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 3.1% in the morning session after JPMorgan raised its price target on the company's stock. JPMorgan increased its price target to $25... 
Via StockStory
A Glimpse Into The Expert Outlook On Progyny Through 5 Analysts
 
Via Benzinga
3 Cash-Heavy Stocks with Questionable Fundamentals
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
1 Russell 2000 Stock with Impressive Fundamentals and 2 We Ignore
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
Progyny (PGNY) Stock Is Up, What You Need To Know
Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 3.1% in the afternoon session after continued positive momentum as the company reported stronger-than-expected second-quarter results... 
Via StockStory
Topics Economy
NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy
Progyny Inc (NASDAQ:PGNY) – A Prime Affordable Growth Stock with Strong Fundamentals and Fair Valuation
Progyny (PGNY) offers strong growth potential with 38% revenue growth, 32% EPS outlook, and fair valuation (P/E 24.75). Debt-free with solid profitability, it aligns with the Affordable Growth strategy... 
Via Chartmill
PGNY Q2 Deep Dive: Product Expansion and Client Diversification Drive Upbeat Guidance
Fertility benefits company Progyny (NASDAQ:PGNY) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 9.5% year on year to $332.9 million. Guidance for next quarter’s... 
Via StockStory
1 Cash-Producing Stock with Promising Prospects and 2 We Ignore
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Progyny (NASDAQ:PGNY) Beats Expectations in Strong Q2, Full-Year Sales Guidance is Optimistic
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 9.5% year on year to $332.9 million. Guidance for next quarter’s... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.